These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28801862)

  • 21. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets.
    Tsuchiya A; Brazier J; Roberts J
    J Health Econ; 2006 Mar; 25(2):334-46. PubMed ID: 16271783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A computer Time Trade-Off: a feasible and reliable alternative for the interview Time Trade-Off in rheumatoid arthritis.
    Buitinga L; Braakman-Jansen LM; Taal E; van de Laar MA
    Clin Exp Rheumatol; 2011; 29(5):783-9. PubMed ID: 21961923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility, reliability, and validity of three health-state valuation methods using multiple-outcome vignettes on moderate-risk pregnancy at term.
    Bijlenga D; Birnie E; Bonsel GJ
    Value Health; 2009; 12(5):821-7. PubMed ID: 19508667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health state utilities and subjective well-being among psoriasis vulgaris patients in mainland China.
    Liu L; Li S; Zhao Y; Zhang J; Chen G
    Qual Life Res; 2018 May; 27(5):1323-1333. PubMed ID: 29492743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sagittal craniosynostosis: a utility outcomes study.
    Kuta V; McNeely PD; Walling S; Bezuhly M
    J Neurosurg Pediatr; 2017 Aug; 20(2):113-118. PubMed ID: 28524791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of population-based utility weights for health states of chronic kidney disease, dialysis and kidney transplantation.
    Jo MW; Lee HJ; Ryu DR; Park J; Ock M; Kim SH
    Nephrology (Carlton); 2020 Jul; 25(7):544-550. PubMed ID: 32026549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiplicative modelling of EQ-5D-3L TTO and VAS values.
    Shafie AA; Vasan Thakumar A
    Eur J Health Econ; 2020 Dec; 21(9):1411-1420. PubMed ID: 32892230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility Measures in Pediatric Temporary Health States: Comparison of Prone Positioning Valuation Through 5 Assessment Tools.
    Shahjouei S; Vafaei Sadr A; Khorasani S; Nejat F; Habibi Z; Akbari Sari A
    Value Health Reg Issues; 2019 May; 18():97-105. PubMed ID: 30897544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods.
    Craig BM; Busschbach JJ; Salomon JA
    Med Care; 2009 Jun; 47(6):634-41. PubMed ID: 19433996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valuation of Health States Considered to Be Worse Than Death-An Analysis of Composite Time Trade-Off Data From 5 EQ-5D-5L Valuation Studies.
    Gandhi M; Rand K; Luo N
    Value Health; 2019 Mar; 22(3):370-376. PubMed ID: 30832976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is it going to be, TTO or SG? A direct test of the validity of health state valuation.
    Lipman SA; Brouwer WBF; Attema AE
    Health Econ; 2020 Nov; 29(11):1475-1481. PubMed ID: 32744408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
    Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
    Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement and comparison of health utility assessments in chronic rhinosinusitis.
    Ference EH; Stubbs V; Lidder AK; Chandra RK; Conley D; Avila PC; Hirsch AG; Min JY; Smith SS; Kern RC; Tan BK
    Int Forum Allergy Rhinol; 2015 Oct; 5(10):929-36. PubMed ID: 26077390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment and preferences for current health.
    King JT; Tsevat J; Roberts MS
    Health Qual Life Outcomes; 2009 Jan; 7():1. PubMed ID: 19134191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability of computerized visual analog scale, time trade-off and standard gamble rating methods in patients and the public.
    Lenert LA; Sturley AE
    Proc AMIA Symp; 2001; ():364-8. PubMed ID: 11825211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interrelationships between heath utility measurements, disease activity and psychological factors in Behçet's disease.
    Murray PI; Sekaran A; Javidi H; Situnayake D
    Gen Hosp Psychiatry; 2021; 70():103-108. PubMed ID: 33799105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valuing Health State: An EQ-5D-5L Value Set for Ethiopians.
    Welie AG; Gebretekle GB; Stolk E; Mukuria C; Krahn MD; Enquoselassie F; Fenta TG
    Value Health Reg Issues; 2020 Sep; 22():7-14. PubMed ID: 31683254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Argentine valuation of the EQ-5D health states.
    Augustovski FA; Irazola VE; Velazquez AP; Gibbons L; Craig BM
    Value Health; 2009 Jun; 12(4):587-96. PubMed ID: 19900257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off.
    Jiang R; Shaw J; Mühlbacher A; Lee TA; Walton S; Kohlmann T; Norman R; Pickard AS
    Qual Life Res; 2021 May; 30(5):1433-1444. PubMed ID: 33247810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.